Technical Analysis for HRTX - Heron Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 18.18 -1.46% -0.27
HRTX closed down 1.46 percent on Monday, July 22, 2019, on 86 percent of normal volume. It was able to find support at its 50 day moving average.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical HRTX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Support Bullish 0.00%
Fell Below 20 DMA Bearish -1.46%
Slingshot Bullish Bullish Swing Setup -1.46%
Overbought Stochastic Strength -1.46%
NR7 Range Contraction -5.31%
Stochastic Reached Overbought Strength -5.31%
Upper Bollinger Band Walk Strength -5.31%
BB Squeeze Ended Range Expansion -5.31%
Overbought Stochastic Strength -5.31%

Older signals for HRTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Medicine Health Pharmaceutical Clinical Medicine Oncology Chemotherapy Cancer Treatments Antineoplastic Drugs Occupational Safety And Health Drug Delivery Injectable Pharmaceuticals
Is HRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 22 FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, CLDR and PYX
Jul 22 CLASS ACTION UPDATE for LTHM, HRTX and BOX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Jul 22 UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Jul 22 Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder
Jul 21 FILING DEADLINE - Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of LTHM, HRTX and ASNA
Jul 20 ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important August 5th Deadline in the Securities Class Action – HRTX
Jul 19 SHAREHOLDER ALERT: BE HRTX DBD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Jul 19 CLASS ACTION UPDATE for HRTX, CLDR and BUD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Jul 19 SHAREHOLDER ALERT: HL HRTX CLDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Jul 19 Metro Bank PLC (MBNKF), Heron Therapeutics, Inc. (HRTX) & Beazer Homes USA, Inc. (BZH) - Bronstein, Gewirtz & Grossman, LLC Class Action
See more HRTX news...
Indicators
Indicator Value
52 Week High 41.55
52 Week Low 16.2
Average Volume 771,441
200-Day Moving Average 24.02
50-Day Moving Average 18.0704
20-Day Moving Average 18.4815
10-Day Moving Average 18.66
Average True Range 0.7285
ADX 12.67
+DI 18.0794
-DI 24.7438
Chandelier Exit (Long, 3 ATRs ) 17.1645
Chandelier Exit (Short, 3 ATRs ) 19.6855
Upper Bollinger Band 19.2794
Lower Bollinger Band 17.6836
Percent B (%b) 0.31
BandWidth 8.634581
MACD Line 0.0933
MACD Signal Line 0.0887
MACD Histogram 0.0045
Fundamentals Value
Market Cap 984.22 Million
Num Shares 54.1 Million
EPS -4.15
Price-to-Earnings (P/E) Ratio -4.38
Price-to-Sales 59.70
Price-to-Book 11.60
PEG Ratio -0.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.25
Resistance 3 (R3) 19.31 19.01 19.07
Resistance 2 (R2) 19.01 18.74 18.98 19.01
Resistance 1 (R1) 18.60 18.57 18.45 18.54 18.95
Pivot Point 18.30 18.30 18.23 18.27 18.30
Support 1 (S1) 17.89 18.03 17.74 17.83 17.41
Support 2 (S2) 17.59 17.86 17.56 17.35
Support 3 (S3) 17.18 17.59 17.29
Support 4 (S4) 17.12